Related Experiment Video
Updated: Jul 18, 2026

Intratracheal Instillation of Stem Cells in Term Neonatal Rats
Published on: May 4, 2020
Prevention of bronchopulmonary dysplasia: finally, something that works
1David Geffen School of Medicine at UCLA, Torrance, USA.
Insights
Bronchopulmonary dysplasia (BPD) in premature infants is linked to disrupted Parathyroid Hormone-related Protein (PTHrP) signaling. Stabilizing this pathway with PTHrP agonists may offer a novel therapeutic approach for BPD.
Area of Science:
- Neonatal Medicine
- Molecular Biology
- Pulmonary Medicine
Background:
- Bronchopulmonary dysplasia (BPD) is a significant cause of infant mortality.
- Current understanding of BPD pathogenesis is limited, lacking effective interventions.
- Molecular mechanisms underlying BPD require further elucidation.
Purpose of the Study:
- To investigate the molecular mechanisms of BPD pathogenesis.
- To identify key signaling pathways involved in BPD.
- To explore novel therapeutic targets for BPD.
Main Methods:
- Basic biologic approach to study BPD pathophysiology.
- Investigated the role of Parathyroid Hormone-related Protein (PTHrP) signaling.
- Utilized exogenous PTHrP agonists in preclinical models.
Main Results:
- Disruption of alveolar PTHrP signaling is central to BPD pathogenesis.
- Stabilization of PTHrP signaling prevents and rescues molecular injuries.
- Exogenous PTHrP agonists show potential in preventing/treating BPD.
Conclusions:
- PTHrP signaling is a critical target for BPD intervention.
- Exogenous PTHrP agonists represent a novel therapeutic strategy for BPD.
- Further animal model testing is required before human trials.
Abstract:
Due to a lack of understanding of the molecular mechanisms involved in its pathogenesis, bronchopulmonary dysplasia (BPD) still remains a major cause of morbidity and mortality in the premature infant and there is no effective preventive and/or therapeutic intervention. We have taken a basic biologic approach to elucidate the pathophysiology of BPD and have discovered that disruption of the alveolar Parathyroid Hormone-related Protein (PTHrP) signaling is centrally involved in this process. Further, stabilization of this signaling pathway by using exogenous PTHrP agonists can prevent and/or rescue the molecular injuries caused by insults that lead to BPD. Based upon years of work in this field, here I provide a novel and innovative molecular approach, i.e, exogenous treatment with PTHrP pathway agonists to prevent and/or treat BPD. However, to avoid any later surprises, it is important to emphasize that before translating it into human trials, this approach needs further testing and refinement in animal models.
Related Concept Videos
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Respiratory Syncytial Virus Disease
COPD: Management Using Bronchodilators and Corticosteroids
Breathing
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Pulmonary Cycle: Exhalation
